About this trial
The purpose of this study is to evaluate whether changing the volume and concentration of a medication affects the quality of pain relief and the side effects associated with labor epidural analgesia.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
18 years of age or older
Gestational age of 36 weeks or greater
American Society of Anesthesiology physical status 2
Induction of labor or early labor (cervical dilation < 6cm)
Disqualifiers
Preeclampsia
Receiving magnesium sulfate
Having received narcotics within 4 hours
Multiple gestation
Trial design
Parallel
Treatments tested in this trial
administration of bupivacaine 7.5 mg and fentanyl 24 mcg every 40 minutes
DrugDose of medication delivered using a programmed intermittent epidural bolus
Treatment groups
Trial outcomes
Primary outcomes
Patient controlled boluses received
The number of patient-controlled boluses received by the patient by pressing the patient-controlled analgesia (PCA) button for additional pain relief
Secondary outcomes
Patient controlled boluses requests
The number of patient controlled boluses requested by pressing the PCA button for additional pain relief
Physician administered epidural bolus
The number of times that a physician supplies additional medication for the control of pain
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: